Profile
| Metric | Value |
|---|---|
| Full Name | Savara Inc. |
| Ticker | NASDAQ: SVRA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | savarapharma.com |
| Employees | 59 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $5.77 | |
| Price, 1D Change | +4.15% | |
| Market Cap | $1B | |
| - | ||
| PE Ratio | - | |
| Beta | 0.82 | |
| Revenue | $0 | |
| Revenue, 1Y Change | 0.00% | |
| EPS | -$0.48 | |
| EPS, 1Y Change | -46.12% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:70 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$0.48 | |
| EPS Estimate | -$0.52 | |
| EPS Est. Change | -6.80% | |
| Revenue | $0.00 | |
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| Current Price | $5.77 | |
| Price Target | - | $10.25 |
| Price Tgt. Change | - | +77.64% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.35 | -$0.33 | +5.40% | |
| -$0.49 | -$0.48 | +0.25% | |
| -$0.52 | N/A | -6.80% | |
| -$0.40 | N/A | +17.32% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| $14.01M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | +89.18% | |
| Price, 3Y | +231.61% | |
| Market Cap, 1Y | +123.24% | |
| Market Cap, 3Y | +491.62% | |
| Revenue, 1Y | 0.00% | |
| Revenue, 3Y | 0.00% | |
| EPS, 1Y | -46.12% | |
| EPS, 3Y | -50.62% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $5.77 | |
| SMA 200 | $3.55 | |
| SMA 200 vs Price | -38.40% | |
| SMA 50 | $5.40 | |
| SMA 50 vs Price | -6.40% | |
| Beta | 0.82 | |
| ATR | $0.36 | |
| 14-Day RSI | 47.15 | |
| 10-Day Volatility | 51.25% | |
| 1-Year Volatility | 71.08% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $0.00 | |
| EPS | -$0.48 | |
| Gross Profit | -$275.00K | |
| Gross Margin | - | |
| Operating Profit | -$102.40M | |
| Operating Margin | - | |
| Net Income | -$95.88M | |
| Net Margin | - | |
| EBITDA | -$102.27M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.16 | |
| 13.73 | ||
| 13.73 | ||
| - | ||
| - | ||
| 13.25 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| - | ||
| 12.44 | ||
| -8.92 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $171.45M | |
| $15.13M | ||
| $212.88M | ||
| $202.14M | ||
| $41.43M | ||
| $14.72M | ||
| Total Debt | $26.82M | |
| $116.00K | ||
| $4.55M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $102.40M | ||
| $102.40M | ||
| $275.00K | ||
| $25.04M | ||
| $130.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$89.09M | ||
| -$39.94M | ||
| $117.58M | ||
| Capex | $25.00K | |
| -$89.11M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Wells Fargo | → | |
| Oppenheimer | → | |
| Citizens | → | |
| JMP Securities | → | |
| Guggenheim | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → | |
| Oppenheimer | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with SVRA
Data Sources & References
- SVRA Official Website www.savarapharma.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1160308/000119312525277525/0001193125-25-277525-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1160308/000095017025045731/0000950170-25-045731-index.htm
- SVRA Profile on Yahoo Finance finance.yahoo.com/quote/SVRA
- SVRA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/svra
FAQ
What is the ticker symbol for Savara Inc.?
The ticker symbol for Savara Inc. is NASDAQ:SVRA
Does Savara Inc. pay dividends?
No, Savara Inc. does not pay dividends
What sector is Savara Inc. in?
Savara Inc. is in the Healthcare sector
What industry is Savara Inc. in?
Savara Inc. is in the Biotechnology industry
What country is Savara Inc. based in?
Savara Inc. is headquartered in United States
When did Savara Inc. go public?
Savara Inc. initial public offering (IPO) was on April 28, 2017
Is Savara Inc. in the S&P 500?
No, Savara Inc. is not included in the S&P 500 index
Is Savara Inc. in the NASDAQ 100?
No, Savara Inc. is not included in the NASDAQ 100 index
Is Savara Inc. in the Dow Jones?
No, Savara Inc. is not included in the Dow Jones index
When was Savara Inc. last earnings report?
Savara Inc.'s most recent earnings report was on November 12, 2025
When does Savara Inc. report earnings?
The next expected earnings date for Savara Inc. is March 31, 2026